The Quest to Cure Myeloma: Mission Accomplished?

The Quest to Cure Myeloma: Mission Accomplished?

by Charles Bankhead – MedPageToday – Long-term survival in the CARTITUDE-1 trial showed that almost half of patients remained, alive with a median overall survival (OS) of 60.7 months. Almost three-fourths of the survivors remained progression free, and...